Selected research
Market Structure
Global Non-Therapeutic Antibiotics for Food Animals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Non-Therapeutic Antibiotics for Food Animals market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Non-Therapeutic Antibiotics for Food Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Non-Therapeutic Antibiotics for Food Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non-Therapeutic Antibiotics for Food Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Non-Therapeutic Antibiotics for Food Animals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Non-Therapeutic Antibiotics for Food Animals include AG Zoetis, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck & Co., Inc., Bayer AG, AG Sanofi, Ceva Sante Animale, Virbac and Vetoquinol S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Non-Therapeutic Antibiotics for Food Animals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Non-Therapeutic Antibiotics for Food Animals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Non-Therapeutic Antibiotics for Food Animals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Therapeutic Antibiotics for Food Animals market size, projected growth trends, production technologies, key applications, and end-use industries.
Non-Therapeutic Antibiotics for Food Animals Segment by Company
AG Zoetis, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck & Co., Inc.
Bayer AG
AG Sanofi
Ceva Sante Animale
Virbac
Vetoquinol S.A.
Dechra Pharmaceuticals
Non-Therapeutic Antibiotics for Food Animals Segment by Type
Oxytetracyclines
Tylosin
Ampicillin and Amoxycillin
Gentamicin
Sulfaquinoxaline
Salinomycin
Bacitracin
Others
Non-Therapeutic Antibiotics for Food Animals Segment by Application
Cattle Feed
Poultry Feed
Swine Feed
Aqua Feed
Others
Non-Therapeutic Antibiotics for Food Animals Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Therapeutic Antibiotics for Food Animals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Therapeutic Antibiotics for Food Animals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Therapeutic Antibiotics for Food Animals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Non-Therapeutic Antibiotics for Food Animals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Therapeutic Antibiotics for Food Animals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Therapeutic Antibiotics for Food Animals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Non-Therapeutic Antibiotics for Food Animals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oxytetracyclines
- Tylosin
- Ampicillin and Amoxycillin
- Gentamicin
- Sulfaquinoxaline
- Salinomycin
- Bacitracin
- Others
Applications
- Cattle Feed
- Poultry Feed
- Swine Feed
- Aqua Feed
- Others
Companies covered
- AG Zoetis, Inc.
- Boehringer Ingelheim GmbH
- Eli Lilly and Company
- Merck & Co., Inc.
- Bayer AG
- AG Sanofi
- Ceva Sante Animale
- Virbac
- Vetoquinol S.A.
- Dechra Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Non-Therapeutic Antibiotics for Food Animals Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Non-Therapeutic Antibiotics for Food Animals Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Non-Therapeutic Antibiotics for Food Animals Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Non-Therapeutic Antibiotics for Food Animals Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Non-Therapeutic Antibiotics for Food Animals Market Dynamics
- 2.1 Non-Therapeutic Antibiotics for Food Animals Industry Trends
- 2.2 Non-Therapeutic Antibiotics for Food Animals Industry Drivers
- 2.3 Non-Therapeutic Antibiotics for Food Animals Industry Opportunities and Challenges
- 2.4 Non-Therapeutic Antibiotics for Food Animals Industry Restraints
3 Non-Therapeutic Antibiotics for Food Animals Market by Manufacturers
- 3.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Manufacturers (2021-2026)
- 3.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Manufacturers (2021-2026)
- 3.3 Global Non-Therapeutic Antibiotics for Food Animals Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Non-Therapeutic Antibiotics for Food Animals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Non-Therapeutic Antibiotics for Food Animals Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Non-Therapeutic Antibiotics for Food Animals Manufacturers, Product Type & Application
- 3.7 Global Non-Therapeutic Antibiotics for Food Animals Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Non-Therapeutic Antibiotics for Food Animals Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Non-Therapeutic Antibiotics for Food Animals Players Market Share by Revenue in 2025
- 3.8.3 2025 Non-Therapeutic Antibiotics for Food Animals Tier 1, Tier 2, and Tier 3
4 Non-Therapeutic Antibiotics for Food Animals Market by Type
- 4.1 Non-Therapeutic Antibiotics for Food Animals Type Introduction
- 4.1.1 Oxytetracyclines
- 4.1.2 Tylosin
- 4.1.3 Ampicillin and Amoxycillin
- 4.1.4 Gentamicin
- 4.1.5 Sulfaquinoxaline
- 4.1.6 Salinomycin
- 4.1.7 Bacitracin
- 4.1.8 Others
- 4.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Type
- 4.2.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Type (2021-2032)
- 4.2.3 Global Non-Therapeutic Antibiotics for Food Animals Sales Market Share by Type (2021-2032)
- 4.3 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Type
- 4.3.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Type (2021-2032)
- 4.3.3 Global Non-Therapeutic Antibiotics for Food Animals Revenue Market Share by Type (2021-2032)
5 Non-Therapeutic Antibiotics for Food Animals Market by Application
- 5.1 Non-Therapeutic Antibiotics for Food Animals Application Introduction
- 5.1.1 Cattle Feed
- 5.1.2 Poultry Feed
- 5.1.3 Swine Feed
- 5.1.4 Aqua Feed
- 5.1.5 Others
- 5.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Application
- 5.2.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Application (2021-2032)
- 5.2.3 Global Non-Therapeutic Antibiotics for Food Animals Sales Market Share by Application (2021-2032)
- 5.3 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Application
- 5.3.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Application (2021-2032)
- 5.3.3 Global Non-Therapeutic Antibiotics for Food Animals Revenue Market Share by Application (2021-2032)
6 Global Non-Therapeutic Antibiotics for Food Animals Sales by Region
- 6.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Non-Therapeutic Antibiotics for Food Animals Sales by Region (2021-2032)
- 6.2.1 Global Non-Therapeutic Antibiotics for Food Animals Sales by Region (2021-2026)
- 6.2.2 Global Non-Therapeutic Antibiotics for Food Animals Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Non-Therapeutic Antibiotics for Food Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Non-Therapeutic Antibiotics for Food Animals Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Non-Therapeutic Antibiotics for Food Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Non-Therapeutic Antibiotics for Food Animals Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Non-Therapeutic Antibiotics for Food Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Non-Therapeutic Antibiotics for Food Animals Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Non-Therapeutic Antibiotics for Food Animals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Non-Therapeutic Antibiotics for Food Animals Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Region
- 7.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Region
- 7.1.1 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Region (2021-2026)
- 7.1.3 Global Non-Therapeutic Antibiotics for Food Animals Revenue by Region (2027-2032)
- 7.1.4 Global Non-Therapeutic Antibiotics for Food Animals Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Non-Therapeutic Antibiotics for Food Animals Revenue (2021-2032)
- 7.2.2 North America Non-Therapeutic Antibiotics for Food Animals Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Non-Therapeutic Antibiotics for Food Animals Revenue (2021-2032)
- 7.3.2 Europe Non-Therapeutic Antibiotics for Food Animals Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Non-Therapeutic Antibiotics for Food Animals Revenue (2021-2032)
- 7.4.2 Asia-Pacific Non-Therapeutic Antibiotics for Food Animals Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Non-Therapeutic Antibiotics for Food Animals Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Non-Therapeutic Antibiotics for Food Animals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 AG Zoetis, Inc.
- 8.1.1 AG Zoetis, Inc. Company Information
- 8.1.2 AG Zoetis, Inc. Business Overview
- 8.1.3 AG Zoetis, Inc. Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 AG Zoetis, Inc. Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.1.5 AG Zoetis, Inc. Recent Developments
- 8.2 Boehringer Ingelheim GmbH
- 8.2.1 Boehringer Ingelheim GmbH Company Information
- 8.2.2 Boehringer Ingelheim GmbH Business Overview
- 8.2.3 Boehringer Ingelheim GmbH Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim GmbH Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.2.5 Boehringer Ingelheim GmbH Recent Developments
- 8.3 Eli Lilly and Company
- 8.3.1 Eli Lilly and Company Company Information
- 8.3.2 Eli Lilly and Company Business Overview
- 8.3.3 Eli Lilly and Company Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Eli Lilly and Company Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.3.5 Eli Lilly and Company Recent Developments
- 8.4 Merck & Co., Inc.
- 8.4.1 Merck & Co., Inc. Company Information
- 8.4.2 Merck & Co., Inc. Business Overview
- 8.4.3 Merck & Co., Inc. Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck & Co., Inc. Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.4.5 Merck & Co., Inc. Recent Developments
- 8.5 Bayer AG
- 8.5.1 Bayer AG Company Information
- 8.5.2 Bayer AG Business Overview
- 8.5.3 Bayer AG Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Bayer AG Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.5.5 Bayer AG Recent Developments
- 8.6 AG Sanofi
- 8.6.1 AG Sanofi Company Information
- 8.6.2 AG Sanofi Business Overview
- 8.6.3 AG Sanofi Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 AG Sanofi Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.6.5 AG Sanofi Recent Developments
- 8.7 Ceva Sante Animale
- 8.7.1 Ceva Sante Animale Company Information
- 8.7.2 Ceva Sante Animale Business Overview
- 8.7.3 Ceva Sante Animale Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Ceva Sante Animale Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.7.5 Ceva Sante Animale Recent Developments
- 8.8 Virbac
- 8.8.1 Virbac Company Information
- 8.8.2 Virbac Business Overview
- 8.8.3 Virbac Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Virbac Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.8.5 Virbac Recent Developments
- 8.9 Vetoquinol S.A.
- 8.9.1 Vetoquinol S.A. Company Information
- 8.9.2 Vetoquinol S.A. Business Overview
- 8.9.3 Vetoquinol S.A. Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Vetoquinol S.A. Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.9.5 Vetoquinol S.A. Recent Developments
- 8.10 Dechra Pharmaceuticals
- 8.10.1 Dechra Pharmaceuticals Company Information
- 8.10.2 Dechra Pharmaceuticals Business Overview
- 8.10.3 Dechra Pharmaceuticals Non-Therapeutic Antibiotics for Food Animals Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Dechra Pharmaceuticals Non-Therapeutic Antibiotics for Food Animals Product Portfolio
- 8.10.5 Dechra Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Non-Therapeutic Antibiotics for Food Animals Value Chain Analysis
- 9.1.1 Non-Therapeutic Antibiotics for Food Animals Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Non-Therapeutic Antibiotics for Food Animals Production Mode & Process
- 9.2 Non-Therapeutic Antibiotics for Food Animals Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Non-Therapeutic Antibiotics for Food Animals Distributors
- 9.2.3 Non-Therapeutic Antibiotics for Food Animals Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst